论文部分内容阅读
背景:非甾体类抗炎药(NSAIDs)已经被证实可以减轻炎症和多种肿瘤的患病风险,然而,它们对于肝细胞癌的患病风险及由于慢性肝病所导致的死亡的影响,目前尚无相关研究。
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of inflammation and various cancers. However, their impact on the risk of hepatocellular carcinoma and death due to chronic liver disease are currently No relevant research yet.